Literature DB >> 5263687

Genetic variations in the acetylation of isoniazid and other drugs.

D A Evans.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5263687     DOI: 10.1111/j.1749-6632.1968.tb48255.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  25 in total

1.  Serum concentrations and bioavailability of rifampicin and isoniazid in combination.

Authors:  J C Garnham; T Taylor; P Turner; L F Chasseaud
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

2.  Pharmacokinetics of isoniazid and some metabolites in man.

Authors:  H G Boxenbaum; S Riegelman
Journal:  J Pharmacokinet Biopharm       Date:  1976-08

3.  Pharmacokinetics of isoniazid metabolism in man.

Authors:  G A Ellard; P T Gammon
Journal:  J Pharmacokinet Biopharm       Date:  1976-04

Review 4.  Disease and acetylation polymorphism.

Authors:  P K Lunde; K Frislid; V Hansteen
Journal:  Clin Pharmacokinet       Date:  1977 May-Jun       Impact factor: 6.447

5.  Antinuclear factor in rapid and slow acetylator patients treated with isoniazid.

Authors:  D A Evans; M F Bullen; J Houston; C A Hopkins; J M Vetters
Journal:  J Med Genet       Date:  1972-03       Impact factor: 6.318

6.  The determination of isoniazid and its metabolites acetylisoniazid, monoacetylhydrazine, diacetylhydrazine, isonicotinic acid and isonicotinylglycine in serum and urine.

Authors:  G A Ellard; P T Gammon; S M Wallace
Journal:  Biochem J       Date:  1972-02       Impact factor: 3.857

7.  Isoniazid N-acetyltransferase polymorphism and serotonin metabolism.

Authors:  W Schloot; H W Goedde
Journal:  Humangenetik       Date:  1970

8.  Defective N-oxidation of sparteine in man: a new pharmacogenetic defect.

Authors:  M Eichelbaum; N Spannbrucker; B Steincke; H J Dengler
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

9.  An evaluation of the potential use of isoniazid, acetylisoniazid and isonicotinic acid for monitoring the self-administration of drugs.

Authors:  G A Ellard; P J Jenner; P A Downs
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

10.  Diabetic dimorphism according to acetylator status.

Authors:  A W Burrows; T D Hockaday; J I Mann; J G Taylor
Journal:  Br Med J       Date:  1978-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.